Direct healthcare costs for patients with asthma are less than half (-52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP.
Ronco, R., Franco, G., Monzio Compagnoni, M., Aliberti, S., Luppi, F., Corrao, G., et al. (2023). Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD. ERJ OPEN RESEARCH, 9(4), 1-4 [10.1183/23120541.00158-2023].
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
Ronco, Raffaella;Franco, Giovanni;Monzio Compagnoni, Matteo;Luppi, Fabrizio;Faverio, Paola
2023
Abstract
Direct healthcare costs for patients with asthma are less than half (-52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
